Issue 8, 2024

Correction: A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer

Abstract

Correction for ‘A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer’ by Yinjie Wang et al., Biomater. Sci., 2019, 7, 4748–4757, https://doi.org/10.1039/C9BM00337A.

Associated articles

Article information

Article type
Correction
Submitted
18 Mar 2024
Accepted
18 Mar 2024
First published
22 Mar 2024
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2024,12, 2165-2166

Correction: A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer

Y. Wang, Z. Jiang, B. Yuan, Y. Tian, L. Xiang, Y. Li, Y. Yang, J. Li and A. Wu, Biomater. Sci., 2024, 12, 2165 DOI: 10.1039/D4BM90022G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements